首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   11881篇
  免费   924篇
  国内免费   719篇
  2024年   15篇
  2023年   143篇
  2022年   295篇
  2021年   470篇
  2020年   341篇
  2019年   395篇
  2018年   408篇
  2017年   329篇
  2016年   530篇
  2015年   704篇
  2014年   822篇
  2013年   900篇
  2012年   1073篇
  2011年   993篇
  2010年   624篇
  2009年   537篇
  2008年   640篇
  2007年   584篇
  2006年   504篇
  2005年   455篇
  2004年   423篇
  2003年   404篇
  2002年   386篇
  2001年   200篇
  2000年   167篇
  1999年   141篇
  1998年   103篇
  1997年   92篇
  1996年   88篇
  1995年   67篇
  1994年   74篇
  1993年   62篇
  1992年   75篇
  1991年   61篇
  1990年   60篇
  1989年   45篇
  1988年   29篇
  1987年   22篇
  1986年   36篇
  1985年   27篇
  1984年   34篇
  1983年   10篇
  1982年   16篇
  1981年   15篇
  1980年   13篇
  1979年   9篇
  1978年   8篇
  1977年   12篇
  1976年   11篇
  1975年   11篇
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
1.
2.
Many studies have examined the association between the FABP2 (rs1799883) Ala54Thr gene polymorphism and type 2 diabetes mellitus risk (T2DM) in various populations, but their results have been inconsistent. To assess this relationship more precisely, A HuGE review and meta‐analysis were performed. The PubMed and CNKI database was searched for case‐control studies published up to April 2014. Data were extracted and pooled odds ratios (OR) with 95% confidence intervals (CI) were calculated. Ultimately, 13 studies, comprising 2020 T2DM cases and 2910 controls were included. Overall, for the Thr carriers (Ala/Thr and Thr/Thr) versus the wild‐type homozygotes (Ala/Ala), the pooled OR was 1.18 (95% CI = 1.04–1.34, P = 0.062 for heterogeneity), for Thr/Thr versus Ala/Ala the pooled OR was 1.17 (95% CI = 1.05–1.41 P = 0.087 for heterogeneity). In the stratified analysis by ethnicity, the significantly risks were found among Asians but not Caucasians. This meta‐analysis suggests that the FABP2 (rs1799883) Ala54Thr polymorphisms are associated with increased susceptibility to T2DM risk among Asians but not Caucasians.  相似文献   
3.
Ren  Xinwei  Tang  Jingchun  Wang  Lan  Liu  Qinglong 《Plant and Soil》2021,462(1-2):561-576
Plant and Soil - To investigate the effects of polystyrene microplastics (PS-beads) on the soil properties, photosynthesis of Flowering Chinese cabbage, the rhizosphere microbial community and...  相似文献   
4.
5.
<正>Aristolochic acids, mutational signature, and hepatocellular carcinoma Aristolochic acids (AA) are the etiologic agents of aristolochic acid nephropathy (AAN) and contribute to the global prevalence of chronic kidney disease and urothelial cancer (Grollman et al., 2007). DNA adducts formed by AA generate a unique AT transversions mutation spectrum at  相似文献   
6.
7.
8.
9.
10.
Phenol red is widely used in cell culture as a pH indicator. Recently, it also has been reported to have estrogen-like bioactivity and be capable of promoting cell proliferation in different cell lines. However, the effect of phenol red on primary neuronal culture has never been investigated. By using patch clamp technique, we demonstrated that hippocampal pyramidal neurons cultured in neurobasal medium containing no phenol red had large depolarization-associated epileptiform bursting activities, which were rarely seen in neurons cultured in phenol red-containing medium. Further experiment data indicate that the suppressive effect of the phenol red on the abnormal epileptiform burst neuronal activities was U-shape dose related, with the most effective concentration at 28 µM. In addition, this concentration related inhibitory effect of phenol red on the epileptiform neuronal discharges was mimicked by 17-β-estradiol, an estrogen receptor agonist, and inhibited by ICI-182,780, an estrogen receptor antagonist. Our results suggest that estrogen receptor activation by phenol red in the culture medium prevents formation of abnormal, epileptiform burst activity. These studies highlight the importance of phenol red as estrogen receptor stimulator and cautions of careful use of phenol red in cell culture media.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号